These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24880048)

  • 1. Brain penetration assessment in vivo: a reliable and simple method in anesthetized rats at steady state.
    Andersen CA; Perfetti P; Nibbio M; Bellini M; Angelini R; Fornasier M
    J Neurosci Methods; 2014 Jul; 232():199-206. PubMed ID: 24880048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
    Fortuna A; Alves G; Soares-da-Silva P; Falcão A
    Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usage.
    Fu T; Gao R; Scott-Stevens P; Chen Y; Zhang C; Wang J; Summerfield S; Liu H; Sahi J
    Eur J Pharm Sci; 2018 Sep; 122():13-21. PubMed ID: 29857045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of dexmedetomidine administered intravenously in isoflurane-anesthetized cats.
    Escobar A; Pypendop BH; Siao KT; Stanley SD; Ilkiw JE
    Am J Vet Res; 2012 Feb; 73(2):285-9. PubMed ID: 22280391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M
    Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry.
    Zhang MY; Kerns E; McConnell O; Sonnenberg-Reines J; Zaleska MM; Steven Jacobsen J; Butera J; Kreft A
    J Pharm Biomed Anal; 2004 Feb; 34(2):359-68. PubMed ID: 15013150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dose and input rate on the brain penetration of BMS-204352 following intravenous administration to rats.
    Krishna R; Palme H; Zeng J; Srinivas N
    Biopharm Drug Dispos; 2002 Sep; 23(6):227-31. PubMed ID: 12214322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability, food effect and tolerability of S-naproxen betainate sodium salt monohydrate in steady state.
    Marzo A; Dal Bo L; Wool C; Cerutti R
    Arzneimittelforschung; 1998 Sep; 48(9):935-40. PubMed ID: 9793622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
    Kallem R; Kulkarni CP; Patel D; Thakur M; Sinz M; Singh SP; Mahammad SS; Mandlekar S
    Drug Metab Lett; 2012 Jun; 6(2):134-44. PubMed ID: 23061481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of brain and plasma drug concentrations by liquid chromatography/tandem mass spectrometry.
    Tamvakopoulos CS; Colwell LF; Barakat K; Fenyk-Melody J; Griffin PR; Nargund R; Palucki B; Sebhat I; Shen X; Stearns RA
    Rapid Commun Mass Spectrom; 2000; 14(19):1729-35. PubMed ID: 11006579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of perfusion in determining brain penetration (brain-to-plasma ratios) of small molecules in rats.
    Fenyk-Melody JE; Shen X; Peng Q; Pikounis W; Colwell L; Pivnichny J; Anderson LC; Tamvakopoulos CS
    Comp Med; 2004 Aug; 54(4):378-81. PubMed ID: 15357317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen.
    Cox S; Villarino N; Sommardahl C; Kvaternick V; Zarabadipour C; Siger L; Yarbrough J; Amicucci A; Reed K; Breeding D; Doherty T
    Vet J; 2013 Nov; 198(2):382-5. PubMed ID: 24076125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the novel antifolate pemetrexed to the brain.
    Dai H; Chen Y; Elmquist WF
    J Pharmacol Exp Ther; 2005 Oct; 315(1):222-9. PubMed ID: 15987831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography-tandem mass spectrometry.
    Hou J; Qu F; Wu C; Ren Q; Zhang J
    J Pharm Biomed Anal; 2012 Jul; 66():232-9. PubMed ID: 22472186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro.
    Ding Y; Liu W; Lu C; Yang J; Zhu Y; Song Y; Ma Z; Yang L; Jia Y; Wen A
    Biomed Pharmacother; 2012 Mar; 66(2):98-102. PubMed ID: 22264880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.